Literature DB >> 7263860

Relationship between platelet secretion and prothrombin cleavage in native whole blood.

M E Rybak, H K Lau, B Tomkins, R D Rosenberg, R I Handin.   

Abstract

To determine the relationship between platelet secretion and prothrombin conversion in whole blood, the release of platelet factor 4 and the generation of a X(a)-specific cleavage product of prothrombin, fragment 1 + 2, were measured during the coagulation of whole blood. There was a parallel increase in the concentration of the two proteins. Over the first 5 min of incubation, platelet factor 4 concentration increased 6 ng/ml per min, and after 6-7 min, the rate of release increased to 750 ng/ml per min. Over the initial 5-7 min of incubation, fragment 1 + 2 concentration increased 1.5 pmol/ml per min with a subsequent increase of 45 pmol/ml per min. Incubation with 10 muM prostaglandin E(1) or 15 muM prostaglandin I(2) inhibited secretion of platelet factor 4 and delayed the onset of the rapid phase of fragment 1 + 2 generation by 8 min, while stimulation of platelet secretion with 1 mug/ml collagen suspension enhanced production of fragment 1 + 2. The addition of either 10 muM epinephrine or 100 ng/ml collagen suspension to whole blood did not affect either platelet factor 4 release or fragment 1 + 2 generation, although the combination of 3 muM epinephrine and 100 ng/ml collagen suspension enhanced platelet release and prothrombin cleavage. The relationship between platelet factor 4 release and prothrombin cleavage was also studied in Factor VIII-deficient blood. When 0.001 U/ml factor VIII activity was present, <80 ng/ml platelet factor 4 were released, and no fragment 1 + 2 was generated after 30 min of incubation. The addition of 0.008-0.08 U/ml Factor VIII activity progressively increased platelet factor 4 release and prothrombin cleavage. Platelet factor 4 release was normal at 0.08 U/ml Factor VIII activity, whereas prothrombin cleavage was still delayed. Very little thrombin, the amount generated by the cleavage of 3-5 nM fragment 1 + 2, was needed to induce release of platelet factor 4.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7263860      PMCID: PMC370812          DOI: 10.1172/jci110269

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies.

Authors:  R R PROCTOR; S I RAPAPORT
Journal:  Am J Clin Pathol       Date:  1961-09       Impact factor: 2.493

2.  A radioimmunoassay for platelet factor 4.

Authors:  A E Bolton; C A Ludlam; D S Pepper; S Moore; J D Cash
Journal:  Thromb Res       Date:  1976-01       Impact factor: 3.944

3.  Binding of the products of prothrombin activation to human platelets.

Authors:  D M Tollefsen; C M Jackson; P W Majerus
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

Review 4.  Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays.

Authors:  D Rodbard
Journal:  Clin Chem       Date:  1974-10       Impact factor: 8.327

Review 5.  Prothrombin structure, activation, and biosynthesis.

Authors:  J W Suttie; C M Jackson
Journal:  Physiol Rev       Date:  1977-01       Impact factor: 37.312

6.  Human prothrombin activation.

Authors:  M R Downing; R J Butkowski; M M Clark; K G Mann
Journal:  J Biol Chem       Date:  1975-12-10       Impact factor: 5.157

7.  Purification and binding properties of human platelet factor four.

Authors:  R I Handin; H J Cohen
Journal:  J Biol Chem       Date:  1976-07-25       Impact factor: 5.157

8.  Factors responsible for ADP-induced release reaction of human platelets.

Authors:  J F Mustard; D W Perry; R L Kinlough-Rathbone; M A Packham
Journal:  Am J Physiol       Date:  1975-06

9.  Interaction of coagulation factor Xa with human platelets.

Authors:  J P Miletich; C M Jackson; P W Majerus
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

10.  The measurement of thrombin in clotting blood by radioimmunoassay.

Authors:  M A Shuman; P W Majerus
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

View more
  2 in total

1.  Protection of factor Xa from neutralization by the heparin-antithrombin complex.

Authors:  J M Teitel; R D Rosenberg
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

2.  Evaluation of the prothrombin fragment 1.2 in patients with coronavirus disease 2019 (COVID-19).

Authors:  Hanny Al-Samkari; Fei Song; Elizabeth M Van Cott; David J Kuter; Rachel Rosovsky
Journal:  Am J Hematol       Date:  2020-09-02       Impact factor: 13.265

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.